細胞培養の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

細胞培養の世界市場規模は、2022年に282億米ドルと評価され、予測期間（2024-2031年）のCAGRは13.50%で、2023年の320億1,000万米ドルから2031年には881億5,000万米ドルに成長する見通しです。

世界の細胞培養市場は、その応用に関する認知度の向上と、特にがん研究のための旺盛な研究資金によって大きな成長を遂げています。この拡大は、洗練された細胞培養技術の進歩によってさらに強化されています。In vitroの細胞培養では、組織から細胞を分離し、植物や動物由来のものを排除した制御された環境で培養します。この人工的な環境は、必要不可欠な栄養素で最適化され、適切なpHレベル、湿度、ガス、温度を維持し、細胞の成長と増殖を促進します。培養に用いる細胞は、酵素を用いたり機械的な抽出法を用いたりすることができ、研究者は確立された細胞株や菌株を実験に利用することができます。このプロセスは、増殖条件を確立するのに重要な化学薬品を含む、様々な機器や消耗品に依存しています。制御された物理化学的環境、様々な成長因子、ホルモン、ガス、基質、培地などの重要な構成要素は、効率的な細胞培養操作に不可欠です。全体として、この市場は技術の進化とライフサイエンス分野での研究開発重視の高まりに後押しされた有望な動向を示しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 価格分析
• 技術分析
• 特許分析
• バリューチェーン分析
• サプライチェーン分析
• 規制情勢
• 顧客と購買基準の分析

細胞培養市場：製品別

• 市場概要
• 消耗品
  • 血清、培地、試薬
  • メディア
  • 無血清培地
  • 古典的培地と塩
  • 幹細胞培養培地
  • 化学的に定義された培地
  • 専門培地
  • その他の培地
  • 試薬
  • 成長因子
  • サプリメント
  • 緩衝剤と化学薬品
  • 細胞分離試薬
  • バランス塩溶液
  • 愛着とマトリックス要因
  • 抗生物質/抗真菌剤
  • 凍結防止試薬
  • 汚染検出キット
  • その他の試薬
  • セラ
  • ウシ胎児血清
  • 成牛血清
  • その他の動物血清
  • 船舶
  • セルファクトリーシステム/セルスタック
  • ローラー/ルーボトル
  • フラスコ
  • マルチウェルプレート
  • ペトリ皿
  • アクセサリー
• 装置
  • バイオリアクター
  • 従来のバイオリアクター
  • 使い捨てバイオリアクター
  • 保管設備
  • 冷蔵庫・冷凍庫
  • 冷凍保存システム
  • その他の機器
  • 濾過システム
  • 細胞カウンター
  • 二酸化炭素インキュベーター
  • 遠心分離機
  • オートクレーブ
  • 顕微鏡
  • バイオセーフティキャビネット
  • その他の補助機器

細胞培養市場：用途別

• 市場概要
• バイオ医薬品製造
  • モノクローナル抗体の生産
  • ワクチン製造
  • その他の治療用タンパク質の生産
• 診断
• 組織工学と再生医療
  • 細胞・遺伝子治療
  • その他の組織工学および再生医療の応用
• 医薬品のスクリーニングと開発
• その他の用途

細胞培養市場：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 病院および診断研究所
• 研究・学術機関
• その他のエンドユーザー

細胞培養市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• Merck KGAA（Germany）
• Sartorius AG（Germany）
• Corning Incorporated（US）
• Fujifilm Holdings Corporation（Japan）
• BD（Becton, Dickinson and Company）（US）
• Eppendorf SE（Germany）
• Lonza（Switzerland）
• Getinge AB（Sweden）
• Agilent Technologies, Inc.（US）
• Himedia Laboratories（India）
• Bio-Techne（US）
• Miltenyi Biotec（Germany）
• Stemcell Technologies（Canada）
• Solida Biotech GmbH（Germany）
• Caisson Labs Inc.（US）
• Promocell GmbH（Germany）
• Invivogen（US）
• Pan-Biotech（Germany）
• Cellexus（UK）
• Meissner Filtration Products, Inc.（US）
• Adolf Kuhner AG（Switzerland）
• Advancion Corporation（US）
• Biospherix, Ltd.（US）

Global Cell Culture Market size was valued at USD 28.2 billion in 2022 and is poised to grow from USD 32.01 billion in 2023 to USD 88.15 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The global cell culture market is witnessing significant growth driven by increased awareness regarding its applications and robust funding for research, particularly in cancer studies. This expansion is further bolstered by advancements in sophisticated cell culture technologies. In vitro cell culture involves isolating cells from tissues and nurturing them in a controlled environment devoid of plant or animal sources. This artificial setup is optimized with essential nutrients, maintaining appropriate pH levels, humidity, gases, and temperature to facilitate cell growth and proliferation. Cells for culture can be sourced through enzyme-based or mechanical extraction methods, and researchers can utilize established cell lines or strains for their experiments. The process relies on various instruments and consumables, including chemicals that are critical for establishing the growth conditions. Essential components such as a controlled physico-chemical environment, along with various growth factors, hormones, gases, substrates, and media, are vital for efficient cell culture operations. Overall, the market demonstrates promising trends fueled by technological evolution and a growing emphasis on research development within the life sciences field.

Top-down and bottom-up approaches were used to estimate and validate the size of the global cell culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global cell culture Market Segmental Analysis

Global Cell Culture Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Diagnostics, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global cell culture Market

The surge in demand for biopharmaceuticals, particularly cell-based therapies and monoclonal antibodies, is a significant market driver for the global cell culture market. This trend is largely influenced by the rising prevalence of chronic diseases, including diabetes, cancer, and autoimmune disorders, which require advanced therapeutic solutions. As a result, the pharmaceutical industry increasingly relies on sophisticated cell culture techniques for large-scale production, research, and development of these biologics. This growing need for effective treatment options not only propels innovation in cell culture technologies but also expands the market, fostering investments and advancements in the sector to meet regulatory and production demands.

Restraints in the global cell culture Market

The global cell culture market faces significant restraints due to ethical concerns surrounding the use of stem cells and animal-derived components in research and product development. These ethical dilemmas are particularly pronounced in regions with stringent regulatory frameworks, where compliance can become an onerous process that stifles innovation. The necessity to navigate complex regulations not only complicates the approval of cell-based products but also hinders the entry of new players into the market. As a result, these challenges can limit the overall growth potential of the cell culture market, leading to reduced investment and slower advancements in biotechnological applications.

Market Trends of the global cell culture Market

The global cell culture market is experiencing a significant shift towards 3D cell culture systems, reflecting a growing preference for models that more accurately mimic in vivo conditions compared to traditional 2D systems. This trend is revolutionizing drug discovery, cancer research, and toxicity testing by enhancing the physiological relevance of experimental results. As stakeholders seek improved efficacy in therapeutic development and better human tissue modeling, the adoption of 3D technologies is projected to accelerate. With advancing biotechnologies and increasing investments in research and development, the market is poised for robust growth, solidifying 3D cell culture as a critical component in biomedical research and pharmaceutical innovation.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Cell Culture Market by Product

• Market Overview
• Consumables
  • Sera, Media, and Reagents
  • Media
  • Serum-Free Media
  • Classical Media & Salts
  • Stem Cell Culture Media
  • Chemically Defined Media
  • Specialty Media
  • Other Media
  • Reagents
  • Growth Factors
  • Supplements
  • Buffers & Chemicals
  • Cell Dissociation Reagents
  • Balanced Salt Solutions
  • Attachment & Matrix Factors
  • Antibiotics/Antimycotics
  • Cryoprotective Reagents
  • Contamination Detection Kits
  • Other Reagents
  • Sera
  • Fetal Bovine Sera
  • Adult Bovine Sera
  • Other Animal Sera
  • Vessels
  • Cell Factory Systems/Cell Stacks
  • Roller/Roux Bottles
  • Flasks
  • Multiwell Plates
  • Petri Dishes
  • Accessories
• Equipment
  • Bioreactors
  • Conventional Bioreactors
  • Single-Use Bioreactors
  • Storage Equipment
  • Refrigerators & Freezers
  • Cryostorage Systems
  • Other Equipment
  • Filtration Systems
  • Cell Counters
  • Carbon Dioxide Incubators
  • Centrifuges
  • Autoclaves
  • Microscopes
  • Biosafety Cabinets
  • Other Supporting Equipment

Cell Culture Market by Application

• Market Overview
• Biopharmaceutical Production
  • Monoclonal Antibody Production
  • Vaccine Production
  • Other Therapeutic Protein Production
• Diagnostics
• Tissue Engineering & Regenerative Medicine
  • Cell & Gene Therapy
  • Other Tissue Engineering & Regenerative Medicine Applications
• Drug Screening & Development
• Other Applications

Cell Culture Market by End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

Cell Culture Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solida Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caisson Labs Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promocell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invivogen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pan-Biotech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellexus (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adolf Kuhner AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advancion Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biospherix, Ltd. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments